Precision Biosciences (DTIL) Debt to Equity (2021 - 2025)
Historic Debt to Equity for Precision Biosciences (DTIL) over the last 4 years, with Q3 2025 value amounting to $1.35.
- Precision Biosciences' Debt to Equity rose 29164.07% to $1.35 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.35, marking a year-over-year increase of 29164.07%. This contributed to the annual value of $0.4 for FY2024, which is 6669.02% down from last year.
- Precision Biosciences' Debt to Equity amounted to $1.35 in Q3 2025, which was up 29164.07% from $0.66 recorded in Q2 2025.
- Precision Biosciences' 5-year Debt to Equity high stood at $1.35 for Q3 2025, and its period low was $0.02 during Q2 2021.
- In the last 4 years, Precision Biosciences' Debt to Equity had a median value of $0.53 in 2025 and averaged $0.56.
- In the last 5 years, Precision Biosciences' Debt to Equity plummeted by 6669.02% in 2024 and then surged by 29164.07% in 2025.
- Precision Biosciences' Debt to Equity (Quarter) stood at $0.02 in 2021, then surged by 4812.06% to $1.19 in 2023, then crashed by 66.69% to $0.4 in 2024, then soared by 239.83% to $1.35 in 2025.
- Its Debt to Equity stands at $1.35 for Q3 2025, versus $0.66 for Q2 2025 and $0.45 for Q1 2025.